Abhinav Jain - 16 Aug 2023 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Director
Signature
/s/ Mark Oki as attorney-in-fact for Abhinav Jain
Issuer symbol
AYTU
Transactions as of
16 Aug 2023
Net transactions value
$0
Form type
4
Filing time
18 Aug 2023, 18:27:05 UTC
Previous filing
15 Aug 2023
Next filing
23 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Shares Award $0 +6,500 +433% $0.000000 8,000 16 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares, which vest as follows: 1/3 on June 14, 2024, with the remaining restricted shares vesting in eight equal installments every three months, beginning on September 14, 2024.